Your browser doesn't support javascript.
loading
Anticipated Barriers to Sustained Engagement in Treatment With Medications for Opioid Use Disorder After Release From Incarceration.
Kaplowitz, Eliana; Truong, Ashley; Macmadu, Alexandria; Berk, Justin; Martin, Harrison; Burke, Caroline; Rich, Josiah D; Brinkley-Rubinstein, Lauren.
Afiliación
  • Kaplowitz E; From the Center for Health + Justice Transformation, The Miriam Hospital, Providence, RI (EK, AM, HM, JDR, LB-R); Center of Biomedical Research Excellence on Opioids and Overdose, The Rhode Island Hospital, Providence, RI (EK, JDR); Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (AT); Rhode Island Department of Corrections, Cranston, RI (AM, JB); Brown University School of Medicine, Providence, RI (JB, JDR); Wesleyan University, Middletown, CT (HM); S
J Addict Med ; 17(1): 54-59, 2023.
Article en En | MEDLINE | ID: mdl-35916404
ABSTRACT

BACKGROUND:

Although the burden of opioid use disorder is disproportionately high among persons who are incarcerated, medications for opioid use disorder are often unavailable in correctional settings. The Rhode Island Department of Corrections provides all 3 classes of medications for opioid use disorder to clinically eligible persons who are incarcerated. Despite a decrease in fatal overdoses among persons with recent criminal legal system involvement since the program's implementation, barriers to continued engagement in treatment after release from incarceration still exist.

METHODS:

We conducted 40 semistructured, qualitative interviews with people who were incarcerated and enrolled in the comprehensive medications for opioid use disorder program at the Rhode Island Department of Corrections. Analysis applied a general, inductive approach using NVivo 12.

RESULTS:

Participants discussed barriers to treatment engagement before incarceration, as well as anticipated barriers to medications to treat opioid use disorder continuation after release from incarceration. Structural factors including housing, health insurance, transportation, and the treatment program structure, as well as social factors such as social support networks were perceived to influence retention in medications to treat opioid use disorder post-release.

CONCLUSION:

Our findings suggest that people with opioid use disorder who are incarcerated encounter unique challenges upon community reentry. Addressing structural factors that pose barriers to post-release engagement is essential to sustaining retention. We recommend utilization of peer recovery specialists to alleviate some of the stress of navigating the structural barriers identified by participants.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Prisioneros / Criminales / Sobredosis de Droga / Trastornos Relacionados con Opioides Tipo de estudio: Prognostic_studies / Qualitative_research Aspecto: Equity_inequality Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: J Addict Med Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Prisioneros / Criminales / Sobredosis de Droga / Trastornos Relacionados con Opioides Tipo de estudio: Prognostic_studies / Qualitative_research Aspecto: Equity_inequality Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: J Addict Med Año: 2023 Tipo del documento: Article